Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Buy Us a Coffee
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2023-32607
Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Stored cross-site scripting vulnerability in Pleasanter (Community Edition and Enterprise Edition) 1.3.39.2 and earlier versions allows a remote authenticated attacker to inject an arbitrary script.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Pleasanter 跨站脚本漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Pleasanter是Pleasanter公司的一款免费的 OSS 无代码/低代码开发工具。 Pleasanter 1.3.39.2版本及之前版本存在安全漏洞。攻击者利用该漏洞可以在登录用户的 Web 浏览器上执行任意脚本。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
Implem Inc.Pleasanter (Community Edition and Enterprise Edition) 1.3.39.2 and earlier versions -
II. Public POCs for CVE-2023-32607
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2023-32607
Please Login to view more intelligence information
IV. Related Vulnerabilities
Same product: Pleasanter (Community Edition and Enterprise Edition)
Same vendor: Implem Inc.
V. Comments for CVE-2023-32607

No comments yet

Leave a comment